Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference
Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference Seattle, WA -- (November 26, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development o ...
Kineta Invited to Participate at October 2019 Investor Conferences
Kineta Invited to Participate at October 2019 Investor Conferences Seattle, WA -- (October 7, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunother ...
Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Investment Conference
Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Investment Conference Seattle, WA -- (August 28, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the deve ...
Kineta Invited to Participate at Solebury Trout’s 9th Annual CEO Roundtable Conference
Kineta Invited to Participate at Solebury Trout’s 9th Annual CEO Roundtable Conference Seattle, WA -- (August 12, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development ...
Kineta Secures $1.8 Million Funding Boost from Wellcome Trust on Positive Phase 1a Clinical Study Results with LHF-535
Kineta Secures $1.8 Million Funding Boost from Wellcome Trust on Positive Phase 1a Clinical Study Results with LHF-535 Favorable overall safety, tolerability, and pharmacokinetic profile of LHF-535 f ...
Kineta Secures NIAID Grant Worth Up to $5.8M to Evaluate LHF-535 in Arenaviruses
Kineta Secures NIAID Grant Worth Up to $5.8M to Evaluate LHF-535 in Arenaviruses Seattle, WA -- (July 15, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development of nove ...